search
Back to results

Opioid-Sparing Effects of Nurse-Delivered Hypnosis During Breast Cancer Surgery

Primary Purpose

Breast Cancer

Status
Not yet recruiting
Phase
Phase 2
Locations
United States
Study Type
Interventional
Intervention
Group 1
Group 2
Group 3
Sponsored by
M.D. Anderson Cancer Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Breast Cancer

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Men and Women; Age 18 or older; Diagnosed with stage 0/1 BCa; Scheduled for a unilateral, segmental mastectomy ± SLND Able to read, write and speak English or Spanish Able to sign a written informed consent and be willing to follow protocol requirements. Exclusion Criteria: Extreme mobility issues that preclude participating in the study Major thought disorders such as schizophrenia or uncontrolled bipolar disorder or PTSD; Low score on Tellegen Absorption Scale (10 or below, a correlate of hypnotic suggestibility) History of chronic opioid use Current pain 2 or above on 0-10 scale Co-mobilities such as uncontrollable diabetes or hypertension Plastic surgery involvement for oncoplastic reconstruction Have undergone chemotherapy, or if surgery is likely greater than 3 hours Patients with hearing loss that could preclude HS facilitation Known allergy to propofol or other medications used during surgery

Sites / Locations

  • M D Anderson Cancer Center

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Experimental

Experimental

Arm Label

Group 1

Group 2

Group 3

Arm Description

Participants will receive hypnosedation before and during surgery as well as local anesthesia and pain/nausea medications during surgery

Participants will receive hypnosedation before surgery and standard general anesthesia during surgery.

Participants will receive standard general anesthesia alone. You will not receive hypnosedation.

Outcomes

Primary Outcome Measures

Trait/State Anxiety Questionnaire
Trait/State Anxiety Questionnaire will be assessed with the 40-item Spielberger State Trait Anxiety Inventory (STAI)53. The STATE scale is a 20-item scale that provides information about a person's current level of anxiety. The TRAIT scale is a 20-item scale that provides information about a person's general anxiety.

Secondary Outcome Measures

Full Information

First Posted
March 2, 2023
Last Updated
September 1, 2023
Sponsor
M.D. Anderson Cancer Center
Collaborators
National Institutes of Health (NIH)
search

1. Study Identification

Unique Protocol Identification Number
NCT05766891
Brief Title
Opioid-Sparing Effects of Nurse-Delivered Hypnosis During Breast Cancer Surgery
Official Title
Opioid-Sparing Effects of Nurse-Delivered Hypnosis During Breast Cancer Surgery
Study Type
Interventional

2. Study Status

Record Verification Date
September 2023
Overall Recruitment Status
Not yet recruiting
Study Start Date
August 31, 2024 (Anticipated)
Primary Completion Date
December 31, 2026 (Anticipated)
Study Completion Date
December 31, 2028 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
M.D. Anderson Cancer Center
Collaborators
National Institutes of Health (NIH)

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
To hypnosedation alone given before and during surgery on reducing opioid use after surgery compared to standard general anesthesia given alone or with hypnosedation.
Detailed Description
OBJECTIVES The proposed trial will randomize women and men with stage 0/I breast cancer scheduled for a lumpectomy ± sentinel node biopsy to one of three groups: 1) surgery with a local anesthetic, fentanyl, and HS before and during surgery (HS); 2) HS before surgery with usual care general anesthesia (HS-GA; total intravenous anesthesia rendering the patient unconscious with propofol infusion, airway instrumentation with a laryngeal mask airway or endotracheal tube, fentanyl, and local anesthetic); or 3) Usual care general anesthesia same as HS-GA group (GA). This project will allow further exploration of HS during surgery and to explore the biopsychosocial processes associated with analgesia and opioid use, anesthesia, and pain. We will test the hypotheses that HS during breast cancer surgery leads to reduced analgesia and opioid use, less pain and psychological stress, and faster recovery, as well as being more cost effective than GA or HS before surgery with GA. Primary Objective: To determine the efficacy of HS provided by a nurse anesthetist before and during surgery versus HS-GA or GA on reducing morphine equivalent daily dose (MEDD) from day of surgery through post-operative day (POD) 14. Secondary Objectives: To determine the efficacy of HS with local anesthesia vs HS-GA or GA on reducing self-reported and objective pain, anxiety, nausea/vomiting, fatigue, and cognitive dysfunction. To evaluate group differences in costs. Using time and motion studies and methods of economic evaluation, we will test the hypothesis that HS before and during surgery will lead to less time spent in the OR and PACU, lower medication use, and less need for clinical staff engagement, leading to lower overall day of surgery-related costs. To explore psychosocial factors as moderators of the effects of the intervention and predictors of recovery. Baseline psychosocial factors including absorption, state and trait anxiety, intrusive thoughts, and discomfort intolerance, pain sensitivity, and expectations will moderate the effects of HS and predict outcomes over time.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Breast Cancer

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Phase 2, Phase 3
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
225 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Group 1
Arm Type
Experimental
Arm Description
Participants will receive hypnosedation before and during surgery as well as local anesthesia and pain/nausea medications during surgery
Arm Title
Group 2
Arm Type
Experimental
Arm Description
Participants will receive hypnosedation before surgery and standard general anesthesia during surgery.
Arm Title
Group 3
Arm Type
Experimental
Arm Description
Participants will receive standard general anesthesia alone. You will not receive hypnosedation.
Intervention Type
Behavioral
Intervention Name(s)
Group 1
Intervention Description
Participants will receive hypnosedation will be restarted after arriving in the operating room and will continue for the whole time of surgery
Intervention Type
Behavioral
Intervention Name(s)
Group 2
Intervention Description
Participants will receive standard general anesthesia and medications to control your pain after arriving in the operating room
Intervention Type
Behavioral
Intervention Name(s)
Group 3
Intervention Description
Participants will receive standard general anesthesia and medications during surgery to control your pain.
Primary Outcome Measure Information:
Title
Trait/State Anxiety Questionnaire
Description
Trait/State Anxiety Questionnaire will be assessed with the 40-item Spielberger State Trait Anxiety Inventory (STAI)53. The STATE scale is a 20-item scale that provides information about a person's current level of anxiety. The TRAIT scale is a 20-item scale that provides information about a person's general anxiety.
Time Frame
through study completion; an average of 1 year.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Men and Women; Age 18 or older; Diagnosed with stage 0/1 BCa; Scheduled for a unilateral, segmental mastectomy ± SLND Able to read, write and speak English or Spanish Able to sign a written informed consent and be willing to follow protocol requirements. Exclusion Criteria: Extreme mobility issues that preclude participating in the study Major thought disorders such as schizophrenia or uncontrolled bipolar disorder or PTSD; Low score on Tellegen Absorption Scale (10 or below, a correlate of hypnotic suggestibility) History of chronic opioid use Current pain 2 or above on 0-10 scale Co-mobilities such as uncontrollable diabetes or hypertension Plastic surgery involvement for oncoplastic reconstruction Have undergone chemotherapy, or if surgery is likely greater than 3 hours Patients with hearing loss that could preclude HS facilitation Known allergy to propofol or other medications used during surgery
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Lorenzo Cohen, MD
Phone
(713) 745-4260
Email
lcohen@mdanderson.org
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Lorenzo Cohen, MD
Organizational Affiliation
M.D. Anderson Cancer Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
M D Anderson Cancer Center
City
Houston
State/Province
Texas
ZIP/Postal Code
77030
Country
United States
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Lorenzo Cohen, MD
Phone
713-745-4260
Email
lcohen@mdanderson.org
First Name & Middle Initial & Last Name & Degree
Lorenzo Cohen, MD

12. IPD Sharing Statement

Links:
URL
http://www.mdanderson.org
Description
M D Anderson Cancer Center

Learn more about this trial

Opioid-Sparing Effects of Nurse-Delivered Hypnosis During Breast Cancer Surgery

We'll reach out to this number within 24 hrs